Norges Bank Avid Bioservices, Inc. Transaction History

Norges Bank

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$4.64 - $9.56 $838,448 - $1.73 Million	180,700 New	180,700 $1.17 Million
Q3 2023 Nov 13, 2024	BUY	$9.4 - $14.04 $1.51 Million - $2.26 Million	161,000 New	161,000 $1.52 Million
Q3 2023 Nov 13, 2023	SELL	$9.4 - $14.04 $2.21 Million - $3.3 Million	-234,800 Closed	0 $0
Q2 2023 Aug 14, 2023	SELL	$12.96 - $20.93 $3.49 Million - $5.64 Million	-269,400 Closed	0 $0
Q3 2022 Nov 13, 2023	BUY	$15.33 - $20.36 $3.6 Million - $4.78 Million	234,800 New	234,800 $4.49 Million
Q2 2022 Aug 14, 2023	BUY	$11.63 - $21.55 $3.13 Million - $5.81 Million	269,400 New	269,400 $4.11 Million
Q3 2021 Nov 14, 2022	BUY	$19.05 - $28.32 $1.17 Million - $1.74 Million	61,400 New	61,400 $1.32 Million
Q3 2021 Nov 05, 2021	SELL	$19.05 - $28.32 $754,380 - $1.12 Million	-39,600 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$18.93 - $25.65 $749,628 - $1.02 Million	39,600 New	39,600 $1.02 Million
Q1 2021 May 07, 2021	SELL	$11.86 - $21.77 $2.34 Million - $4.29 Million	-197,000 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$7.25 - $11.76 $1.43 Million - $2.32 Million	197,000 New	197,000 $2.27 Million

188

68.4M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.